First Time Loading...

ADC Therapeutics SA
NYSE:ADCT

Watchlist Manager
ADC Therapeutics SA Logo
ADC Therapeutics SA
NYSE:ADCT
Watchlist
Price: 4.72 USD -0.84% Market Closed
Updated: Apr 20, 2024

ADC Therapeutics SA
Selling, General & Administrative

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
TTM
|

ADC Therapeutics SA
Selling, General & Administrative Peer Comparison

Comparables:
ACIU
CRSP
BSLN
IDIA
KURN

Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
ADC Therapeutics SA
NYSE:ADCT
Selling, General & Administrative
$-105.9m
CAGR 3-Years
-4%
CAGR 5-Years
-65%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Selling, General & Administrative
CHf-10.6m
CAGR 3-Years
2%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Selling, General & Administrative
$-206.4m
CAGR 3-Years
-33%
CAGR 5-Years
-34%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Selling, General & Administrative
CHf-33.8m
CAGR 3-Years
-5%
CAGR 5-Years
-1%
CAGR 10-Years
-5%
Idorsia Ltd
SIX:IDIA
Selling, General & Administrative
CHf-504m
CAGR 3-Years
-100%
CAGR 5-Years
-75%
CAGR 10-Years
N/A
Kuros Biosciences AG
SIX:KURN
Selling, General & Administrative
CHf-27.5m
CAGR 3-Years
-44%
CAGR 5-Years
-25%
CAGR 10-Years
N/A

See Also

What is ADC Therapeutics SA's Selling, General & Administrative?
Selling, General & Administrative
-105.9m USD

Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Selling, General & Administrative amounts to -105.9m USD.

What is ADC Therapeutics SA's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-65%

Over the last year, the Selling, General & Administrative growth was 25%. The average annual Selling, General & Administrative growth rates for ADC Therapeutics SA have been -4% over the past three years , -65% over the past five years .